Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROPEGINTERFERON ALFA-2B-NJFT Cause Headache? 135 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Headache have been filed in association with ROPEGINTERFERON ALFA-2B-NJFT. This represents 9.6% of all adverse event reports for ROPEGINTERFERON ALFA-2B-NJFT.

135
Reports of Headache with ROPEGINTERFERON ALFA-2B-NJFT
9.6%
of all ROPEGINTERFERON ALFA-2B-NJFT reports
0
Deaths
8
Hospitalizations

How Dangerous Is Headache From ROPEGINTERFERON ALFA-2B-NJFT?

Of the 135 reports, 8 (5.9%) required hospitalization.

Is Headache Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROPEGINTERFERON ALFA-2B-NJFT. However, 135 reports have been filed with the FAERS database.

What Other Side Effects Does ROPEGINTERFERON ALFA-2B-NJFT Cause?

Fatigue (298) Off label use (210) Pruritus (152) Inappropriate schedule of product administration (103) Product dose omission issue (99) Influenza like illness (97) Nausea (91) Diarrhoea (89) Arthralgia (88) Pain (82)

What Other Drugs Cause Headache?

ADALIMUMAB (19,891) APREMILAST (17,024) ETANERCEPT (14,253) TREPROSTINIL (14,051) METHOTREXATE (11,718) TOFACITINIB (11,061) RITUXIMAB (8,747) TOCILIZUMAB (8,448) INFLIXIMAB (8,387) ABATACEPT (8,184)

Which ROPEGINTERFERON ALFA-2B-NJFT Alternatives Have Lower Headache Risk?

ROPEGINTERFERON ALFA-2B-NJFT vs ROPINIROLE ROPEGINTERFERON ALFA-2B-NJFT vs ROPIVACAINE ROPEGINTERFERON ALFA-2B-NJFT vs ROSIGLITAZONE ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN\ROSUVASTATIN

Related Pages

ROPEGINTERFERON ALFA-2B-NJFT Full Profile All Headache Reports All Drugs Causing Headache ROPEGINTERFERON ALFA-2B-NJFT Demographics